INMUNE BIO INC (INMB) Stock Balance Sheet
NASDAQ:INMB - Nasdaq - US45782T1051 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.34M | 20.92M | 35.85M | 52.15M | 74.81M | |||
| Receivables | 1.42M | 1.41M | 2.44M | 8.46M | 5.50M | |||
| Other Current Assets | 207.00K | 331.00K | 1.65M | 4.06M | 2.29M | |||
| Total Current Assets | 20.96M | 22.66M | 39.94M | 64.68M | 82.61M | |||
| Non-Current Assets | ||||||||
| PPE Net | 278.00K | 307.00K | 414.00K | 510.00K | 730.00K | |||
| Intangibles | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | |||
| Other Non-Current Assets | 49.00K | 79.00K | 131.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 16.84M | 16.90M | 17.06M | 17.12M | 17.34M | |||
| TOTAL ASSETS | 37.80M | 39.56M | 57.00M | 81.80M | 99.95M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 9.92M | 5.00M | N/A | |||
| Accrued Expenses | 146.00K | 140.00K | 119.00K | 90.00K | 70.00K | |||
| Accounts Payable | 7.30M | 6.56M | 7.94M | 5.22M | 3.81M | |||
| Other Current Liabilities | 480.00K | 517.00K | 489.00K | 620.00K | 470.00K | |||
| Total Current Liabilities | 7.93M | 7.22M | 18.46M | 10.92M | 4.36M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 9.70M | 14.46M | |||
| Other Non-Current Liabilities | 201.00K | 244.00K | 397.00K | 1.08M | 900.00K | |||
| Total Non-Current Liabilities | 201.00K | 244.00K | 397.00K | 10.77M | 15.36M | |||
| TOTAL LIABILITIES | 8.13M | 7.46M | 18.86M | 21.69M | 19.72M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -172.84M | -163.10M | -121.02M | -91.01M | -63.72M | |||
| Additional Paid In Capital | 203.10M | 195.75M | 159.14M | 151.80M | 143.92M | |||
| Common Shares | 23.00K | 22.00K | 817.00K | 20.00K | 20.00K | |||
| Other Shareholders' Equity | -610.00K | -575.00K | -799.00K | -700.00K | 0.00 | |||
| Shares Outstanding | 22.93M | 22.28M | 17.95M | 17.95M | 17.84M | |||
| Tangible Book Value per Share | 0.57 | 0.70 | 1.20 | 2.43 | 3.57 | |||
| Total Shareholders' Equity | 29.67M | 32.10M | 38.14M | 60.10M | 80.23M | |||
| TOTAL LIABILITIES AND EQUITY | 37.80M | 39.56M | 57.00M | 81.80M | 99.95M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.16 | 0.18 | |||
| Current Ratio | 2.64 | 3.14 | 2.16 | 5.92 | 18.95 | |||
| Return On Assets (ROA) | -107.92% | -106.37% | -52.64% | -33.37% | -30.36% | |||
| Return On Equity (ROE) | -137.49% | -131.11% | -78.68% | -45.42% | -37.82% | |||
All data in USD , ROIC based on taxRate of 0.21